Add Yahoo as a preferred source to see more of our stories on Google. logos of OpenAI Anadolu via Getty Images There’s interesting news coming from Sam Altman’s empire, a firm known for innovating as ...
Artificial intelligence (AI) companies are well-positioned to disrupt the biotechnology industry. Typically, biotech companies need to invest a huge amount of time, capital, and resources to introduce ...
There is hardly such a thing as a risk-free investment, no matter where you care to look. However, some investments tend to be more risky than others. And in the equity markets, the biotech sector ...
Recursion Pharmaceuticals, a drug discovery company that applies artificial intelligence to biology, is shoring up its technology platform by buying two startups that bolster its chemistry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results